Dyne Therapeutics shareholders elect Hurwitz and Kersten to board, ratify auditor

Dyne Therapeutics, Inc.

Edward Hurwitz elected as Class II director: 20,392,039 for, 7,406,127 withheld, 3,170,612 broker non-votes.
Dirk Kersten elected as Class II director: 20,066,236 for, 7,731,930 withheld, 3,170,612 broker non-votes.
Ratified Deloitte & Touche as auditor for FY2022: 30,967,416 for, 362 against, 1,000 abstain.
Annual meeting held June 3, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.